Corporate Announcement
Security Code : 530019    Company : JUBLPHARMA    
 
Announces Q2 results, Limited Review Report, Results Press Release & Presentation for the Quarter ended September 30, 2015Download PDF
  Exchange Disseminated Time     29/10/2015 15:27:02
Jubilant Life Sciences Ltd has announced the following results for the quarter ended September 30, 2015:

The Un-Audited Standalone results for the Quarter ended September 30, 2015

The Company has posted a net profit of Rs. 509.10 million for the quarter ended September 30, 2015 where as the same was at Rs. 2167.60 million for the quarter ended September 30, 2014. Total Income is Rs. 7458.90 million for the quarter ended September 30, 2015 where as the same was at Rs. 7507.60 million for the quarter ended September 30, 2014.

The Consolidated Results are as follows:

The Unaudited Consolidated results for the Quarter ended September 30, 2015

The Group has posted a net profit after taxes, minority interest and share of profit of associates of Rs. 1158.20 million for the quarter ended September 30, 2015 where as the same was at net loss of Rs. (941.10) million for the quarter ended September 30, 2014. Total Income is Rs. 14675.20 million for the quarter ended September 30, 2015 where as the same was at Rs. 13975.20 million for the quarter ended September 30, 2014.

- Previous periods figures have been reclassified to conform to the current period's classification. Further, the figures for the current period are not comparable to the previous periods due to transfer of certain businesses to Jubilant Generics Limited, a step-down wholly owned subsidiary with effect from July 01, 2014.
 

Disclaimer

Back To Announcements